For individuals with a body mass index (BMI) of 30 kg/m or above (or 27.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds), NICE recommends considering pharmacological interventions alongside lifestyle changes when dietary and exercise modifications alone have been insufficient
A personalized medical evaluation can help determine whether its the right fit for your body and your health goals
These two mechanisms are independent and additive
May 10, 2024
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Today, several GLP-1 diabetes medications are indicated for improving blood sugar control in people with Type 2 diabetes (see table above)